• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Petco Health + Wellness Company, Inc. Reports First Quarter Earnings and Reaffirms Full Year 2023 Guidance

    5/24/23 7:00:00 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary
    Get the next $WOOF alert in real time by email

    Q1 2023 Highlights

    • Comparable sales grew 5.1 percent year-over-year and 10.2 percent on a two-year basis, resulting in the 18th consecutive quarter of comparable sales growth
    • Net revenue of $1.56 billion increased 5.4 percent year-over-year
    • Net loss of $1.9 million, or $(0.01) per diluted share compared to net income of $24.7 million, or $0.09 per diluted share in the prior year
    • Adjusted EBITDA1 of $111.0 million compared to $119.2 million in the prior year, a decrease of 6.9 percent year-over-year
    • Adjusted Earnings Per Share1 of $0.06, compared to $0.14 per share in the prior year, a decrease of $0.08 year-over-year
    • The Company reaffirms its full year 2023 guidance

    SAN DIEGO, May 24, 2023 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), a complete partner in pet health and wellness, today announced its first quarter 2023 financial results. 

    Petco logo (PRNewsfoto/Petco Health and Wellness Company, Inc.)

    In the first quarter of 2023, Petco delivered net revenue of $1.56 billion, up 5.4 percent versus prior year, driven by strength in the company's consumables business, up 11.2 percent versus prior year, and services and other business, up 25.4 percent versus prior year.  First quarter revenue growth was partially offset by the company's supplies and companion animal business, down 7.6 percent versus prior year. Net loss was $1.9 million or $(0.01) per share, driven primarily by a $0.05 per share increase in interest expense year-over-year, compared to net income of $24.7 million or $0.09 per share in the prior year.  Adjusted Net Income1 was $14.9 million or $0.06 per share, compared to $36.3 million or $0.14 per share in the prior year.  Adjusted EBITDA1 was $111.0 million compared to $119.2 million in the prior year.

    In the first quarter of 2023, Petco paid down $35 million in principal on its term loan.  In May 2023, Petco paid down another $25 million in principal on its term loan for a total of $60 million in principal payments year-to-date.  The company continues to target a total of $100 million in principal payments for 2023 and remains committed to strengthening its balance sheet through de-levering long-term.

    "We continue to execute on our strategy amidst the current environment, delivering our 18th consecutive quarter of comp sales growth in the first quarter, driven by the ongoing strength in consumables and record performance in our services business," said Petco CEO Ron Coughlin. "We remain confident in our unique 360-degree pet wellness offering delivered through our core pillars of services, differentiated merchandise, and competitively advantaged omnichannel capabilities all powered by our incredible Petco partners. Looking ahead, we are focused on what's within our control and capitalizing on the secular trends of the resilient pet category to drive long-term, profitable growth." 

    Q1 2023 Operating Results:

    Comparisons are first quarter of fiscal 2023 ended April 29, 2023 versus first quarter of fiscal 2022 ended April 30, 2022 unless otherwise noted.

    • Net revenue increased 5.4 percent to $1.56 billion driven by comparable sales growth of 5.1 percent
    • Net loss of $1.9 million compared to net income of $24.7 million, a decrease of $26.6 million
    • Adjusted Net Income1 decreased $21.4 million to $14.9 million
    • Adjusted EBITDA1 decreased 6.9 percent to $111.0 million
    • Operating cash flow decreased 34.5 percent to $37.7 million
    • Free Cash Flow1 decreased $16.0 million to $(24.4) million

    (1)

    Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share ("Adjusted EPS"), and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

    Fiscal 2023 Guidance:

    The company is reaffirming its fiscal 2023 guidance and expects:

    Metric*

    2023

    Guidance

    Net Revenue

    $6.150 billion to $6.275 billion

    Adjusted EBITDA

    $520 million to $540 million

    Adjusted EPS

    $0.40 to $0.48

    Capital Expenditures

    $225 million to $250 million

    In Fiscal 2023, the company continues to expect to make a total of $100 million in principal payments on its term loan, which is inclusive of $60 million in principal payments on its debt made through May 2023.

    *Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. Adjusted EPS guidance assumes approximately $145 to $155 million of interest expense, an estimated $43 to $53 million increase in interest expense year-over-year, a 26 percent tax rate, and a 273 million weighted average diluted share count. The Company estimates that the increase in interest expense will impact Adjusted EPS by approximately $0.12 to $0.15 per share. Furthermore, Fiscal 2023 will be a 53-week year, leading to an incremental week of operations. Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the SEC.

    Earnings Conference Call Webcast Information:

    Management will host an earnings conference call on May 24, 2023 at 8:00 AM Eastern Time to discuss the company's financial results. The conference call will be accessible through a live webcast. Interested investors and other individuals can access the webcast, earnings release, earnings presentation, and infographic via the company's investor relations page at ir.petco.com. A replay of the webcast will be archived on the company's investor relations page through June 7, 2023 until approximately 5:00 PM Eastern Time.

    About Petco, The Health + Wellness Co.:

    Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S., Mexico and Puerto Rico, which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love (formerly the Petco Foundation), an independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for nearly 7 million animals.

    Forward-Looking Statements:

    This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including statements regarding our fiscal year 2023 guidance. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative", or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation and prevailing interest rates; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflict in Ukraine), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; and (xx) the other risks, uncertainties and other factors identified under "Risk Factors" and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

    Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)





















    13 Weeks Ended







    April 29,

    2023



    April 30,

    2022



    Percent

    Change



    Net sales



    $  1,555,908



    $1,475,991



    5 %



    Cost of sales



    951,426



    868,317



    10 %



    Gross profit



    604,482



    607,674



    (1 %)



    Selling, general and administrative expenses



    576,865



    557,735



    3 %



    Operating income



    27,617



    49,939



    (45 %)



    Interest income



    (1,177)



    (20)



    5,785 %



    Interest expense



    37,202



    19,634



    89 %



    Loss on partial extinguishment of debt



    441



    —



    N/M



    Other non-operating income



    (2,819)



    (314)



    798 %



    (Loss) income before income taxes and income from

       equity method investees



    (6,030)



    30,639



    N/M



    Income tax (benefit) expense



    (1,008)



    10,000



    N/M



    Income from equity method investees



    (3,130)



    (3,163)



    (1 %)



    Net (loss) income



    (1,892)



    23,802



    N/M



    Net loss attributable to noncontrolling interest



    —



    (891)



    (100 %)



    Net (loss) income attributable to Class A and B-1 common

       stockholders



    $       (1,892)



    $     24,693



    N/M



















    Net (loss) income per Class A and B-1 common share:















    Basic



    $         (0.01)



    $        0.09



    N/M



    Diluted



    $         (0.01)



    $        0.09



    N/M



















    Weighted average shares used in computing net (loss) income per Class A

       and B-1 common share:















    Basic



    266,485



    265,050



    1 %



    Diluted



    266,485



    265,701



    0 %



     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)











     April 29,

    2023 



     January 28,

    2023 

    ASSETS









    Current assets:









    Cash and cash equivalents



    $   148,942



    $   201,901

    Receivables, less allowance for credit losses1



    45,414



    49,580

    Merchandise inventories, net



    667,938



    652,430

    Prepaid expenses



    53,290



    51,274

    Other current assets



    61,224



    60,809

    Total current assets



    976,808



    1,015,994

    Fixed assets



    2,041,601



    1,987,560

    Less accumulated depreciation



    (1,229,445)



    (1,184,233)

    Fixed assets, net



    812,156



    803,327

    Operating lease right-of-use assets



    1,378,342



    1,397,761

    Goodwill



    2,194,491



    2,193,941

    Trade name



    1,025,000



    1,025,000

    Other long-term assets



    185,597



    176,806

    Total assets



    $6,572,394



    $6,612,829

    LIABILITIES AND EQUITY









    Current liabilities:









    Accounts payable and book overdrafts



    $   393,795



    $   381,213

    Accrued salaries and employee benefits



    108,760



    89,929

    Accrued expenses and other liabilities



    206,750



    217,556

    Current portion of operating lease liabilities



    281,680



    309,766

    Current portion of long-term debt and other lease liabilities



    5,908



    22,794

    Total current liabilities



    996,893



    1,021,258

    Senior secured credit facilities, net, excluding current portion



    1,612,009



    1,628,331

    Operating lease liabilities, excluding current portion



    1,132,750



    1,148,155

    Deferred taxes, net



    297,779



    303,121

    Other long-term liabilities



    131,843



    130,487

    Total liabilities



    4,171,274



    4,231,352

    Commitments and contingencies









    Stockholders' equity:









    Class A common stock2



    229



    228

    Class B-1 common stock3



    38



    38

    Class B-2 common stock4



    —



    —

    Preferred stock5



    —



    —

    Additional paid-in-capital



    2,173,370



    2,152,342

    Retained earnings



    231,075



    232,967

    Accumulated other comprehensive loss



    (3,592)



    (4,098)

    Total stockholders' equity



    2,401,120



    2,381,477

    Total liabilities and stockholders' equity



    $6,572,394



    $6,612,829





    (1)

    Allowances for credit losses are $949 and $952, respectively

    (2)

    Class A common stock, $0.001 par value: Authorized - 1.0 billion shares; Issued and outstanding - 229.1 million and 228.3 million shares, respectively

    (3)

    Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (4)

    Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (5)

    Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding - none

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited and subject to reclassification)















    13 Weeks Ended





    April 29,

    2023



    April 30,

    2022

    Cash flows from operating activities:









    Net (loss) income



    $   (1,892)



    $  23,802

    Adjustments to reconcile net (loss) income to net cash provided by

      operating activities:









    Depreciation and amortization



    49,255



    46,967

    Amortization of debt discounts and issuance costs



    1,238



    1,224

    Provision for deferred taxes



    (5,530)



    4,832

    Equity-based compensation



    22,129



    12,222

    Impairments, write-offs and losses on sale of fixed and other assets



    4



    162

    Loss on partial extinguishment of debt



    441



    —

    Amounts reclassified out of accumulated other comprehensive loss



    575



    —

    Income from equity method investees



    (3,130)



    (3,163)

    Non-cash operating lease costs



    106,316



    105,249

    Other non-operating income



    (2,819)



    (314)

    Changes in assets and liabilities:









    Receivables



    4,165



    13,397

    Merchandise inventories



    (15,508)



    (6,930)

    Prepaid expenses and other assets



    (12,115)



    (9,896)

    Accounts payable and book overdrafts



    12,582



    (11,314)

    Accrued salaries and employee benefits



    18,982



    (16,478)

    Accrued expenses and other liabilities



    (8,736)



    11,290

    Operating lease liabilities



    (130,297)



    (112,272)

    Other long-term liabilities



    1,991



    (1,259)

        Net cash provided by operating activities



    37,651



    57,519

    Cash flows from investing activities:









    Cash paid for fixed assets



    (62,050)



    (65,910)

    Cash paid for acquisitions, net of cash acquired



    (725)



    —

        Net cash used in investing activities



    (62,775)



    (65,910)

    Cash flows from financing activities:









    Repayments of long-term debt



    (35,000)



    (4,250)

    Payments for finance lease liabilities



    (1,250)



    (1,022)

    Proceeds from employee stock purchase plan and stock option exercises



    1,378



    1,453

    Tax withholdings on stock-based awards



    (2,210)



    (11,441)

        Net cash used in financing activities



    (37,082)



    (15,260)











    Net decrease in cash, cash equivalents and restricted cash



    (62,206)



    (23,651)

    Cash, cash equivalents and restricted cash at beginning of period



    213,727



    221,890

    Cash, cash equivalents and restricted cash at end of period



    $151,521



    $198,239

     

    NON-GAAP FINANCIAL MEASURES

    The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

    The tables below reflect the calculation of Adjusted EBITDA, Adjusted Net Income, and Adjusted EPS, as applicable, for the thirteen weeks ended April 29, 2023 compared to the thirteen weeks ended April 30, 2022, respectively.

    Adjusted EBITDA and Trailing Twelve Month Adjusted EBITDA

    Adjusted EBITDA, including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended January 28, 2023 filed with the SEC on March 28, 2023 for additional information on Adjusted EBITDA.

    (dollars in thousands)



    13 Weeks Ended

    Reconciliation of Net (Loss) Income Attributable to Class A and B-1

       Common Stockholders to Adjusted EBITDA



    April 29,

    2023



    April 30,

    2022

    Net (loss) income attributable to Class A and B-1 common stockholders



    $     (1,892)



    $     24,693

    Add (deduct):









    Interest expense, net



    36,025



    19,614

    Income tax expense



    (1,008)



    10,000

    Depreciation and amortization



    49,255



    46,967

    Income from equity method investees



    (3,130)



    (3,163)

    Loss on partial extinguishment of debt



    441



    —

    Asset impairments and write offs



    4



    162

    Equity-based compensation



    22,129



    12,222

    Other non-operating income



    (2,819)



    (314)

    Mexico joint venture EBITDA (1)



    8,734



    6,778

    Acquisition-related integration costs (2)



    —



    2,236

    Other costs (3)



    3,287



    —

    Adjusted EBITDA



    $   111,026



    $   119,195

    Net sales



    $1,555,908



    $1,475,991

    Net margin (4)



    (0.1 %)



    1.7 %

    Adjusted EBITDA Margin



    7.1 %



    8.1 %

     

    (dollars in thousands)



    Trailing Twelve Months

    Reconciliation of Net Income Attributable to Class A and B-1

       Common Stockholders to Adjusted EBITDA



    April 29,

    2023



    January 28,

    2023



    April 30,

    2022

    Net income attributable to Class A and B-1 common stockholders



    $     64,216



    $     90,801



    $   181,550

    Add (deduct):













    Interest expense, net



    117,022



    100,611



    76,442

    Income tax expense



    24,339



    35,347



    60,795

    Depreciation and amortization



    196,116



    193,828



    177,791

    Income from equity method investees



    (12,943)



    (12,976)



    (11,622)

    Loss on partial extinguishment of debt



    441



    —



    —

    Asset impairments and write offs



    1,834



    1,992



    10,133

    Equity-based compensation



    70,691



    60,784



    49,883

    Other non-operating loss (income)



    10,162



    12,667



    (34,812)

    Mexico joint venture EBITDA (1)



    31,540



    29,584



    27,609

    Acquisition-related integration costs (2)



    13,078



    15,314



    2,236

    Other costs (3)



    6,104



    2,817



    10,995

    Adjusted EBITDA



    $   522,600



    $   530,769



    $   551,000

    Net sales



    $6,115,884



    $6,035,967



    $5,868,146

    Net margin (4)



    1.0 %



    1.5 %



    3.1 %

    Adjusted EBITDA Margin



    8.5 %



    8.8 %



    9.4 %

     

    Adjusted Net Income and Adjusted EPS

    Adjusted Net Income and Adjusted diluted Earnings Per Share attributable to Petco common stockholders (Adjusted EPS) are considered non-GAAP financial measures under the SEC's rules because they exclude certain amounts included in the net income attributable to Petco common stockholders and diluted earnings per share attributable to Petco common stockholders calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they facilitate comparison of the current period performance with that of the comparable prior period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers to be Petco's core earnings performance as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.

    (in thousands, except per share amounts)



    13 Weeks Ended

    Reconciliation of Diluted EPS to Adjusted EPS



    April 29, 2023



    April 30, 2022





    Amount



    Per share



    Amount



    Per share

    Net (loss) income attributable to common stockholders / diluted EPS



    $ (1,892)



    $    (0.01)



    $   24,693



    $     0.09

    Add (deduct):

















    Income tax expense



    (1,008)



    (0.01)



    10,000



    0.04

    Loss on partial extinguishment of debt



    441



    0.00



    —



    —

    Asset impairments and write offs



    4



    0.00



    162



    0.00

    Equity-based compensation



    22,129



    0.10



    12,222



    0.04

    Other non-operating income



    (2,819)



    (0.01)



    (314)



    (0.00)

    Acquisition-related integration costs (2)



    —



    —



    2,236



    0.01

    Other costs (3)



    3,287



    0.01



    —



    —

    Adjusted pre-tax income / diluted earnings per share



    $20,142



    $     0.08



    $   48,999



    $     0.18

    Income tax expense at 26% normalized tax rate



    5,237



    0.02



    12,739



    0.04

    Adjusted Net Income / Adjusted EPS



    $14,905



    $     0.06



    $   36,260



    $     0.14

     

    Free Cash Flow

    Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

    The table below reflects the calculation of Free Cash Flow for the thirteen weeks ended April 29, 2023 and April 30, 2022, respectively.

    (in thousands)



    13 Weeks Ended





    April 29,

    2023



    April 30,

    2022

    Net cash provided by operating activities



    $  37,651



    $     57,519

    Cash paid for fixed assets



    (62,050)



    (65,910)

    Free Cash Flow



    $ (24,399)



    $     (8,391)

     

    Adjusted EBITDA, Adjusted Net Income and Adjusted EPS Footnotes

    (1)

    Mexico Joint Venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes. Because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.









    13 Weeks Ended

    (in thousands)



    April 29,

    2023



    April 30,

    2022

    Net income



    $   6,259



    $   5,133

    Depreciation



    5,708



    4,294

    Income tax expense



    4,074



    2,997

    Foreign currency loss (gain)



    127



    (64)

    Interest expense, net



    1,300



    1,196

    EBITDA



    $ 17,468



    $ 13,556

    50% of EBITDA



    $   8,734



    $   6,778





    (2)

    Acquisition-related integration costs include direct costs resulting from acquiring and integrating businesses. These include third-party professional and legal fees and other integration-related costs that would not have otherwise been incurred as part of the company's operations.

    (3)

    Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.

    (4)

    We define net margin as net income attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-health--wellness-company-inc-reports-first-quarter-earnings-and-reaffirms-full-year-2023-guidance-301832853.html

    SOURCE Petco - Investor Relations

    Get the next $WOOF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WOOF

    DatePrice TargetRatingAnalyst
    4/13/2026$3.83Buy → Neutral
    Goldman
    3/12/2026$5.00Hold → Buy
    Jefferies
    7/19/2024$3.00 → $4.00Neutral
    Citigroup
    4/2/2024$5.00 → $1.50Buy → Underperform
    BofA Securities
    12/19/2023$3.11Hold
    Jefferies
    11/30/2023$8.00 → $3.00Outperform → Neutral
    Robert W. Baird
    11/29/2023Overweight → Equal Weight
    Wells Fargo
    9/29/2023Peer Perform
    Wolfe Research
    More analyst ratings

    $WOOF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Insana Giovanni

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    4/14/26 5:37:37 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Chief Revenue Officer Venezia Patrick J exercised 58,805 shares at a strike of $2.46 and sold $349,072 worth of shares (102,029 units at $3.42), decreasing direct ownership by 10% to 398,832 units (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    3/17/26 4:30:46 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Chief Executive Officer Anderson Joel D disposed of $5,499,999 worth of shares (1,575,931 units at $3.49) (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    3/17/26 4:26:46 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Petco Reports Fourth Quarter and Full Year 2025 Results

    Delivers Profitability Ahead of Outlook, Reduces Leverage Ratio Provides Fiscal 2026 Outlook*SAN DIEGO, March 11, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today reported its fourth quarter and full year 2025 financial results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> "In fiscal 2025, we strengthened our leadership team and rebuilt th

    3/11/26 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on March 11, 2026

    SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced that its financial results for the fourth quarter and full year fiscal 2025 will be released after market close on Wednesday, March 11, 2026. The company will host a conference call at approximately 4:30 p.m. Eastern Time to discuss the results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)">

    2/25/26 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    SEC Filings

    View All

    SEC Form 10-K filed by Petco Health and Wellness Company Inc.

    10-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

    3/13/26 4:06:03 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 144 filed by Petco Health and Wellness Company Inc.

    144 - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    3/13/26 11:21:02 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Health and Wellness Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

    3/11/26 4:10:25 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Anderson Joel D bought $4,717,461 worth of shares (1,586,088 units at $2.97) (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    4/1/25 7:14:43 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Breitner Cameron bought $2,354,325 worth of shares (750,000 units at $3.14) (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    5/29/24 7:35:36 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Briggs Gary S bought $99,924 worth of shares (30,000 units at $3.33), increasing direct ownership by 75% to 70,085 units (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    12/4/23 7:29:44 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Petco Health and Wellness downgraded by Goldman with a new price target

    Goldman downgraded Petco Health and Wellness from Buy to Neutral and set a new price target of $3.83

    4/13/26 8:44:31 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Health and Wellness upgraded by Jefferies with a new price target

    Jefferies upgraded Petco Health and Wellness from Hold to Buy and set a new price target of $5.00

    3/12/26 8:41:26 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Citigroup reiterated coverage on Petco Health and Wellness with a new price target

    Citigroup reiterated coverage of Petco Health and Wellness with a rating of Neutral and set a new price target of $4.00 from $3.00 previously

    7/19/24 8:30:14 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Leadership Updates

    Live Leadership Updates

    View All

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Leslie's Announces Seasoned Retail Executive Amy College as Chief Merchandising and Supply Chain Officer

    PHOENIX, July 15, 2025 (GLOBE NEWSWIRE) -- Leslie's, Inc. (NASDAQ:LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced appointment of Amy College as the company's new Chief Merchandising and Supply Chain Officer effective July 20, 2025. In addition to merchandising, inventory, supply chain, logistics and manufacturing, Ms. College will be responsible for the company's digital marketplace business. In conjunction with Ms. College's appointment, Moyo LaBode, the company's outgoing Chief Merchandising and Supply Chain Officer has left Leslie's, effective July 15, 202

    7/15/25 4:10:43 PM ET
    $LESL
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF THREE PROVEN EXECUTIVES

    Sabrina Simmons Appointed Chief Financial Officer Michael Romanko Appointed Chief Customer and Product Officer Jack Stout Appointed Chief Merchandising Officer SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced the appointment of three new leaders to Petco's executive team to support accelerated operational improvement and position the business for a faster return to profitable growth. Sabrina Simmons, former Chief Financial Officer at Gap, Inc., has been named Chief Financial Officer, effective February 17.Michael

    2/18/25 4:10:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Financials

    Live finance-specific insights

    View All

    Petco Reports Fourth Quarter and Full Year 2025 Results

    Delivers Profitability Ahead of Outlook, Reduces Leverage Ratio Provides Fiscal 2026 Outlook*SAN DIEGO, March 11, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today reported its fourth quarter and full year 2025 financial results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> "In fiscal 2025, we strengthened our leadership team and rebuilt th

    3/11/26 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on March 11, 2026

    SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced that its financial results for the fourth quarter and full year fiscal 2025 will be released after market close on Wednesday, March 11, 2026. The company will host a conference call at approximately 4:30 p.m. Eastern Time to discuss the results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)">

    2/25/26 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Reports Third Quarter 2025 Financial Results

    Upwardly Revises Fiscal 2025 Earnings Outlook* SAN DIEGO, Nov. 25, 2025 /PRNewswire/ -- Petco (NASDAQ:WOOF) today announced its third quarter 2025 financial results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Q3 2025 Overview Net sales of $1.5 billion decreased 3.1% year over year in line with the company's third quarter outlookComparable sales decreased 2.2% year over yearGross profit margin expanded approximately 75 ba

    11/25/25 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

    SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/24 12:55:28 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

    SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/24 6:00:20 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form SC 13G filed by Petco Health and Wellness Company Inc.

    SC 13G - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/22 4:43:20 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary